Search

everythinglearnresearchcommunity

for

Search:↓

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Certain daily habits like stress, diet, and sleep can affect the severity of hair loss in alopecia areata.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

Higher prolactin levels are linked to psoriasis, alopecia areata, and vitiligo severity.

Certain IL-18 gene variations may increase the risk of alopecia areata.

Phototherapy effectively treats certain alopecia areata types, especially if started early.

Combining traditional Chinese medicine with microneedles shows promise for effectively treating skin diseases with fewer side effects.

Vaccines are generally safe, but rare autoimmune reactions can occur, often influenced by genetics.

Blood metabolites significantly influence alopecia areata risk.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

Dupilumab effectively treated severe alopecia areata in a child.

Topical metformin gel is as effective and safe as steroids for treating alopecia areata.

New medications could improve treatment for severe alopecia areata in Australia.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Stem Cell Educator therapy helps regrow hair and improve life quality in alopecia areata patients.

Alopecia areata patients have fewer protective regulatory B cells, which may contribute to the disease.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

FFA patients have fewer melanocytes and thinner skin compared to others.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

COVID-19 can worsen autoimmune skin diseases and increase their occurrence.

Developing human skin has immune cells with memory-like features.

Antihistamines may help with hair regrowth in alopecia areata, but dupilumab's effects are mixed.

Extracellular vesicles show potential in dermatology, but more research is needed for validation.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.